Drugs by condition
Drugs approved for irritable bowel syndrome
Last checked: Nov 20, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations
Brand-name drugs approved
8
Still marketed, NDA or BLA
Drug classes
5
Novel drugs
7
New molecular entities and new biologics
In development
3
Investigational drugs in Phase 2 or 3
Newest approvals
The most recently first-approved brand-name drugs for irritable bowel syndrome.
All approved drugs for irritable bowel syndrome, by class
Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 46 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.
Drugs in development for irritable bowel syndrome
Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.
- BrenipatideLY3537031Phase 313 trials
Eli Lilly · Alcohol Use Disorder, Irritable Bowel Syndrome, Depressive Disorder, Major
- CamlipixantBLU-5937Phase 34 trials
GSK · Refractory Chronic Cough, Cough, Irritable Bowel Syndrome
- TRYP-0082Phase 21 trial
TRYP Therapeutics · Irritable Bowel Syndrome
More on irritable bowel syndrome: recruiting trials · published research
Related in gastroenterology and liver: MASH (fatty liver disease) · Primary biliary cholangitis · Acid reflux (GERD) · Chronic constipation · Nausea and vomiting · Eosinophilic esophagitis
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.